Bangkok Dusit Medical Services Public Company Limited (BDUUY)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Bangkok Dusit Medical Services Public Company Limited (BDUUY) with AI Score 42/100 (Weak). Bangkok Dusit Medical Services (BDMS) is Thailand's largest private hospital operator, managing a network of 47 hospitals across Thailand and Cambodia. Market cap: 0, Sector: Healthcare.
Last analyzed: Mar 15, 2026Bangkok Dusit Medical Services Public Company Limited (BDUUY) Healthcare & Pipeline Overview
Bangkok Dusit Medical Services (BDMS) is a leading healthcare provider in Thailand and Cambodia, operating 47 hospitals and offering diverse medical services, including specialized treatments, wellness programs, and e-commerce. With a strong focus on quality and international patient care, BDMS maintains a significant market share and a robust financial profile.
Investment Thesis
Bangkok Dusit Medical Services presents a compelling investment case based on its dominant market position, diversified service offerings, and strong financial performance. With a market capitalization of $8.11 billion and a profit margin of 14.2%, BDMS demonstrates financial stability. The company's dividend yield of 5.32% offers an attractive income stream for investors. Growth catalysts include increasing medical tourism to Thailand and expanding healthcare services in Cambodia. Potential risks include regulatory changes in the healthcare sector and increased competition from other private hospital operators. The company's beta of 0.27 suggests low volatility compared to the broader market.
Based on FMP financials and quantitative analysis
Key Highlights
- Market capitalization of $8.11 billion, reflecting its strong market position in the healthcare sector.
- Profit margin of 14.2%, indicating efficient operations and profitability.
- Gross margin of 36.1%, showcasing the company's ability to manage costs effectively.
- Dividend yield of 5.32%, providing an attractive income stream for investors.
- Beta of 0.27, suggesting lower volatility compared to the overall market.
Competitors & Peers
Strengths
- Largest private hospital network in Thailand.
- Strong brand reputation for quality and service.
- Comprehensive service offerings.
- Focus on international patient care.
Weaknesses
- High operating costs.
- Dependence on medical tourism.
- Exposure to regulatory changes in the healthcare sector.
- Limited presence in emerging markets.
Catalysts
- Ongoing: Increasing medical tourism to Thailand, driving demand for BDMS's healthcare services.
- Ongoing: Expansion of healthcare services in Cambodia, providing new growth opportunities for BDMS.
- Upcoming: Development of e-commerce platform for health and cosmetic products, expanding BDMS's revenue streams.
- Upcoming: Enhancement of holistic clinical wellness programs, attracting more customers seeking preventive care.
- Ongoing: Investments in advanced medical technology, improving the quality of BDMS's services and attracting more patients.
Risks
- Potential: Increased competition from other private hospital operators, potentially impacting BDMS's market share.
- Potential: Economic downturn affecting medical tourism, reducing demand for BDMS's services.
- Potential: Outbreak of infectious diseases, disrupting BDMS's operations and reducing patient volumes.
- Potential: Changes in government regulations affecting healthcare, potentially increasing BDMS's compliance costs.
- Ongoing: Currency risk associated with the Thai Baht (THB) fluctuating against the U.S. Dollar (USD).
Growth Opportunities
- Expanding medical tourism services: Thailand is a leading destination for medical tourism, attracting patients from around the world seeking affordable and high-quality medical treatments. BDMS can capitalize on this trend by expanding its services for international patients, including specialized treatments, wellness programs, and concierge services. The global medical tourism market is projected to reach $272.7 billion by 2027, offering significant growth potential for BDMS. Timeline: Ongoing.
- Increasing healthcare services in Cambodia: BDMS operates hospitals in Cambodia and can further expand its presence in this market. Cambodia's healthcare sector is growing rapidly, driven by increasing demand for quality medical services and rising disposable incomes. BDMS can leverage its expertise and resources to provide a wider range of healthcare services in Cambodia, including specialized treatments and preventive care programs. Timeline: Ongoing.
- Developing e-commerce platform for health and cosmetic products: BDMS is involved in the e-commerce business and can further develop its platform to sell health and cosmetic products online. The e-commerce market in Thailand is growing rapidly, driven by increasing internet penetration and changing consumer behavior. BDMS can leverage its brand reputation and customer base to capture a significant share of the online health and cosmetic products market. Timeline: Upcoming.
- Enhancing holistic clinical wellness programs: BDMS offers holistic clinical wellness programs and can further enhance these programs to attract more customers. The wellness industry is growing rapidly, driven by increasing awareness of the importance of preventive care and healthy lifestyles. BDMS can develop customized wellness programs tailored to the specific needs of its customers, including nutrition counseling, fitness training, and stress management techniques. Timeline: Upcoming.
- Investing in advanced medical technology: BDMS can invest in advanced medical technology to improve the quality of its services and attract more patients. The healthcare industry is constantly evolving, with new technologies and treatments being developed regularly. BDMS can invest in cutting-edge technologies such as robotic surgery, artificial intelligence, and telemedicine to provide the best possible care for its patients. Timeline: Ongoing.
Opportunities
- Expanding healthcare services in Cambodia.
- Developing e-commerce platform for health and cosmetic products.
- Enhancing holistic clinical wellness programs.
- Investing in advanced medical technology.
Threats
- Increased competition from other private hospital operators.
- Economic downturn affecting medical tourism.
- Outbreak of infectious diseases.
- Changes in government regulations affecting healthcare.
Competitive Advantages
- Extensive network of hospitals: BDMS operates the largest private hospital network in Thailand, providing it with a significant competitive advantage.
- Strong brand reputation: BDMS has a strong brand reputation for quality and service, attracting both domestic and international patients.
- Comprehensive service offerings: BDMS provides a wide range of medical services, including primary, secondary, and tertiary care, as well as specialized treatments and wellness programs.
- Focus on international patient care: BDMS has a strong focus on international patient care, attracting patients from around the world seeking affordable and high-quality medical treatments.
About BDUUY
Bangkok Dusit Medical Services Public Company Limited (BDMS) was established in 1969 and has grown to become the largest private hospital network in Thailand. The company operates 47 hospitals across Thailand and Cambodia, organized under six main hospital groups: Bangkok Hospital Group, Samitivej Hospital Group, BNH Hospital, Phyathai Hospital Group, Paolo Hospital Group, and Royal Hospital Group. BDMS provides a wide range of medical services, including primary, secondary, and tertiary care, as well as specialized treatments in areas such as cardiology, oncology, neurology, and orthopedics. In addition to hospital services, BDMS offers holistic clinical wellness programs, health and cosmetic products, and various support services, including accounting, health insurance, laboratory services, and air medical transportation. BDMS has also expanded into related businesses such as hotels, restaurants, e-commerce, and real estate, aiming to provide a comprehensive healthcare ecosystem. The company focuses on attracting both domestic and international patients, with a strong emphasis on quality, service, and advanced medical technology. BDMS is headquartered in Bangkok, Thailand, and is committed to delivering exceptional healthcare services and enhancing the well-being of its patients.
What They Do
- Operates a network of 47 hospitals in Thailand and Cambodia.
- Provides primary, secondary, and tertiary healthcare services.
- Offers specialized treatments in areas such as cardiology, oncology, and orthopedics.
- Provides holistic clinical wellness programs.
- Sells health and cosmetic products.
- Offers accounting, health insurance, and laboratory services.
- Provides air medical transportation services.
- Operates hotels and restaurants.
Business Model
- Generates revenue from hospital services, including inpatient and outpatient care.
- Earns income from specialized treatments and wellness programs.
- Sells health and cosmetic products through its retail outlets and e-commerce platform.
- Provides support services such as accounting, health insurance, and laboratory services for a fee.
Industry Context
Bangkok Dusit Medical Services operates within the growing healthcare industry in Thailand and Cambodia. The industry is driven by factors such as an aging population, increasing prevalence of chronic diseases, and rising demand for quality healthcare services. Medical tourism is a significant contributor to the industry's growth, with Thailand being a popular destination for international patients seeking affordable and high-quality medical treatments. The competitive landscape includes other private hospital operators such as ALBBY (Alibaba Health Information Technology), BIOVF (Bioventix PLC), CHEOF (China Health Group Inc), CHEOY (China Eastern Med), and CHJTF (China Traditional Chinese Medicine Hldgs Co Ltd). BDMS differentiates itself through its extensive network of hospitals, comprehensive service offerings, and focus on international patient care.
Key Customers
- Domestic patients seeking primary, secondary, and tertiary healthcare services.
- International patients seeking affordable and high-quality medical treatments.
- Individuals seeking specialized treatments and wellness programs.
- Businesses and organizations seeking health insurance and support services for their employees.
Financials
Chart & Info
Bangkok Dusit Medical Services Public Company Limited (BDUUY) stock price: Price data unavailable
Latest News
No recent news available for BDUUY.
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for BDUUY.
Price Targets
Wall Street price target analysis for BDUUY.
MoonshotScore
What does this score mean?
The MoonshotScore rates BDUUY's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Poramaporn Prasarttong-Osoth
Managing Director
Poramaporn Prasarttong-Osoth serves as the Managing Director of Bangkok Dusit Medical Services Public Company Limited. Her career has been dedicated to the healthcare sector, with a focus on hospital management and strategic development. She has been instrumental in driving the company's growth and expansion, overseeing the operations of its extensive network of hospitals. Her leadership emphasizes quality patient care, innovation, and sustainable business practices. She manages a large workforce of over 36,000 employees.
Track Record: Under Poramaporn Prasarttong-Osoth's leadership, Bangkok Dusit Medical Services has strengthened its position as the largest private hospital operator in Thailand. Key achievements include expanding the company's presence in Cambodia, enhancing its service offerings, and improving its financial performance. She has also focused on investing in advanced medical technology and developing innovative healthcare solutions. She has successfully navigated the challenges of the healthcare industry, including regulatory changes and increased competition.
Bangkok Dusit Medical Services Public Company Limited ADR Information Unsponsored
An American Depositary Receipt (ADR) is a certificate representing shares of a foreign company that are held by a U.S. depositary bank. BDUUY is traded on the over-the-counter (OTC) market in the United States, allowing U.S. investors to invest in Bangkok Dusit Medical Services without directly trading on the Stock Exchange of Thailand. ADRs simplify cross-border investing.
- Home Market Ticker: Stock Exchange of Thailand (SET), Bangkok, Thailand
- ADR Level: 1
- ADR Ratio: 1:1
- Home Market Ticker: BDUU
BDUUY OTC Market Information
The OTC Other tier represents the lowest tier of the over-the-counter (OTC) market. Companies in this tier often have limited financial disclosure and may not meet the minimum listing requirements of major exchanges like the NYSE or NASDAQ. Investing in OTC Other stocks carries higher risks due to the lack of regulatory oversight and potential for fraud or manipulation. Investors should exercise caution and conduct thorough due diligence before investing in BDUUY.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure.
- Low trading volume and liquidity.
- Potential for price volatility and manipulation.
- Higher risk of fraud or scams.
- Lack of regulatory oversight.
- Verify the company's registration and legal status.
- Review the company's financial statements (if available).
- Research the company's management team and track record.
- Assess the company's business model and competitive landscape.
- Check for any regulatory actions or legal disputes.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor.
- Established presence in the healthcare industry.
- Extensive network of hospitals in Thailand and Cambodia.
- Strong brand reputation for quality and service.
- Positive financial performance (profit margin of 14.2%).
- Dividend yield of 5.32%.
Bangkok Dusit Medical Services Public Company Limited Stock: Key Questions Answered
What does Bangkok Dusit Medical Services Public Company Limited do?
Bangkok Dusit Medical Services Public Company Limited (BDMS) operates as the largest private hospital network in Thailand and Cambodia, managing 47 hospitals under six main groups. They provide a comprehensive suite of healthcare services, ranging from general medical care to specialized treatments in areas like cardiology and oncology. Additionally, BDMS engages in related businesses such as hotels, restaurants, and e-commerce, aiming to create an integrated healthcare ecosystem catering to both local and international patients seeking quality medical services.
What do analysts say about BDUUY stock?
Based on available financial data, Bangkok Dusit Medical Services (BDUUY) exhibits a solid financial profile with a market capitalization of $8.11 billion and a profit margin of 14.2%. The company's dividend yield of 5.32% suggests a potential income stream for investors. Growth considerations include the expansion of medical tourism and healthcare services in Cambodia. Investors should also consider potential risks such as increased competition and regulatory changes in the healthcare sector. The stock's beta of 0.27 indicates lower volatility compared to the broader market.
What are the main risks for BDUUY?
Bangkok Dusit Medical Services faces several key risks, including increased competition from other private hospital operators in Thailand and Cambodia, which could impact market share and profitability. Economic downturns could reduce medical tourism, a significant revenue source. Outbreaks of infectious diseases could disrupt operations and decrease patient volumes. Changes in government regulations regarding healthcare could increase compliance costs. Currency fluctuations between the Thai Baht and the U.S. Dollar also pose a risk for U.S. investors holding BDUUY.
What are the key factors to evaluate for BDUUY?
Bangkok Dusit Medical Services Public Company Limited (BDUUY) currently holds an AI score of 42/100, indicating low score. Key strength: Largest private hospital network in Thailand.. Primary risk to monitor: Potential: Increased competition from other private hospital operators, potentially impacting BDMS's market share.. This is not financial advice.
How frequently does BDUUY data refresh on this page?
BDUUY prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven BDUUY's recent stock price performance?
Recent price movement in Bangkok Dusit Medical Services Public Company Limited (BDUUY) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Largest private hospital network in Thailand.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider BDUUY overvalued or undervalued right now?
Determining whether Bangkok Dusit Medical Services Public Company Limited (BDUUY) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying BDUUY?
Before investing in Bangkok Dusit Medical Services Public Company Limited (BDUUY), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data and market information are based on available sources and may be subject to change.
- OTC market investments carry higher risks than exchange-listed stocks.
- This analysis is for informational purposes only and does not constitute investment advice.